Table 4.
Unadjusted* | Adjusted ** | ||
Rhinitis | FENO 0.05 | 0.13 (0.06, 0.19) | 0.05 (-0.02, 0.012) |
CawNO | 0.06 (-0.003, 0.12) | 0.01 (-0.06, 0.08) | |
DawNO | 0.08 (0.01, 0.14) | 0.04 (-0.03, 0.11) | |
Asthma | FENO 0.05 | 0.18 (0.09, 0.26) | 0.07 (-0.03, 0.16) |
CawNO | 0.08 (-0.0004, 0.16) | 0.01 (-0.08, 0.10) | |
DawNO | 0.11 (0.03, 0.20) | 0.06 (-0.03, 0.16) | |
Sum of specific IgE | FENO 0.05 | 0.18 (0.13, 0.23) | 0.15 (0.08, 0.21) |
CawNO | 0.10 (0.05, 0.15) | 0.09 (0.03, 0.16) | |
DawNO | 0.10 (0.05, 0.15) | 0.07 (0.01, 0.13) |
The effect estimate was log transformed and presented with a 95% confidence interval.
Subjects using inhaled corticosteroids or oral anti-leukotrienes on a daily basis were excluded from the analysis.
* Adjusted for gender, age, height, FEV1 and smoking history but not adjusted for the variables in the table
** Adjusted both for the variables in the table and gender, age, height, FEV1 and smoking history